The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results